Otomandibular dysplasia associated with monogenic syndromes Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

💰

1Open funds

Regulatory Watchboard

No FDA or trial events recorded yet for Otomandibular dysplasia associated with monogenic syndromes.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Sogroya

Novo Nordisk Pharmaceuticals

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Sogroya

(somapacitan-beco)Orphan drugstandard

Novo Nordisk Pharmaceuticals

12.1 Mechanism of Action Somapacitan-beco binds to a dimeric GH receptor in the cell membrane of target cells resulting in intracellular signal transd...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Otomandibular dysplasia associated with monogenic syndromes.
Search all trials →

Search clinical trials for Otomandibular dysplasia associated with monogenic syndromes →

Recent News & Research

No recent news articles indexed yet for Otomandibular dysplasia associated with monogenic syndromes.
Search PubMed for Otomandibular dysplasia associated with monogenic syndromes →

Browse all Otomandibular dysplasia associated with monogenic syndromes news →

Specialist Network

No specialists currently listed for Otomandibular dysplasia associated with monogenic syndromes.

View all Otomandibular dysplasia associated with monogenic syndromes specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰